{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:35:10Z","timestamp":1786980910583,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10620-024-08575-7","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T04:02:11Z","timestamp":1722312131000},"page":"3375-3381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases"],"prefix":"10.1007","volume":"69","author":[{"given":"Yushan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Lilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin N.","family":"Ananthakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"8575_CR1","doi-asserted-by":"crossref","unstructured":"Forbes JD, Van Domselaar G, Bernstein CN. The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol 2016;7.","DOI":"10.3389\/fmicb.2016.01081"},{"key":"8575_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus","year":"2005","unstructured":"Loftus EV, Harewood GC,  Loftus CG et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005;54:91.","journal-title":"Gut"},{"key":"8575_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/jhg.2015.99","volume":"60","author":"X Wu","year":"2015","unstructured":"Wu X, Chen H, Xu H. The genomic landscape of human immune-mediated diseases. J Hum Genet 2015;60:675\u2013681.","journal-title":"J Hum Genet"},{"key":"8575_CR4","doi-asserted-by":"crossref","unstructured":"Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Off J Am Coll Gastroenterol 2007;102.","DOI":"10.1111\/j.1572-0241.2007.01215.x"},{"key":"8575_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","volume":"129","author":"CN Bernstein","year":"2005","unstructured":"Bernstein CN, Wajda A, Blanchard JF. The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study. Gastroenterology 2005;129:827\u2013836.","journal-title":"Gastroenterology"},{"key":"8575_CR6","doi-asserted-by":"publisher","first-page":"10731","DOI":"10.1038\/s41598-020-67710-2","volume":"10","author":"MJ Garc\u00eda","year":"2020","unstructured":"Garc\u00eda MJ, Pascual M,  Del Pozo C et al. Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach. Sci Rep 2020;10:10731.","journal-title":"Sci Rep"},{"key":"8575_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet 2017;390:1211\u20131259.","journal-title":"The Lancet"},{"key":"8575_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","volume":"83","author":"A Kuek","year":"2007","unstructured":"Kuek A, Hazleman B, Ost\u00f6r A. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 2007;83:251\u2013260.","journal-title":"Postgrad Med J"},{"key":"8575_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2015.04.003","author":"I Mar\u00edn-Jim\u00e9nez","year":"2010","unstructured":"Mar\u00edn-Jim\u00e9nez I, Gisbert JP, P\u00e9rez-Calle JL et al. Incidencia a los 2 a\u00f1os de nuevas enfermedades inflamatorias mediadas por inmunidad en la cohorte de pacientes con enfermedad inflamatoria intestinal del estudio AQUILES. Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.gastrohep.2015.04.003.","journal-title":"Gastroenterol Hepatol"},{"key":"8575_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","volume":"40","author":"AN Collamer","year":"2010","unstructured":"Collamer AN, Battafarano DF. Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis. Semin Arthritis Rheum 2010;40:233\u2013240.","journal-title":"Semin Arthritis Rheum"},{"key":"8575_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/2475530318810851","volume":"4","author":"SJ Li","year":"2018","unstructured":"Li SJ, Perez-Chada LM, Merola JF. TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management. J Psoriasis Psoriatic Arthritis 2018;4:70\u201380.","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"8575_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/art.27203","volume":"62","author":"H-L Ma","year":"2010","unstructured":"Ma H-L,  Napierata L, Stedman N et al. Tumor necrosis factor \u03b1 blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Arthritis Rheum 2010;62:430\u2013440.","journal-title":"Arthritis Rheum"},{"key":"8575_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5070\/D32111029286","volume":"21","author":"H Toda-Brito","year":"2015","unstructured":"Toda-Brito H, Lopes L, Soares-Almeida L, Filipe P. Adalimumab-induced psoriatic alopecia\/alopecia areata-like reaction in a patient with Crohn\u2019s disease. Dermatol Online J 2015;21:11.","journal-title":"Dermatol Online J"},{"key":"8575_CR14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/apt.13352","volume":"42","author":"D Pugliese","year":"2015","unstructured":"Pugliese D, Guidi L,  Ferraro PM et al. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther 2015;42:880\u2013888.","journal-title":"Aliment Pharmacol Ther"},{"key":"8575_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5021\/ad.2021.33.1.82","volume":"33","author":"K Jeong","year":"2021","unstructured":"Jeong K, Seo J-Y, Kim A, Baek Y-S, Song H-J, Jeon J. Tumor Necrosis Factor-Alpha Inhibitor-Associated Psoriatic Alopecia in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature. Ann Dermatol 2021;33:82.","journal-title":"Ann Dermatol"},{"key":"8575_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/apt.16210","volume":"53","author":"C-H Lo","year":"2021","unstructured":"Lo C-H, Khalili H,  Lochhead P et al. Immune-mediated diseases and risk of Crohn\u2019s disease or ulcerative colitis: a prospective cohort study. Aliment Pharmacol Ther 2021;53:598\u2013607.","journal-title":"Aliment Pharmacol Ther"},{"key":"8575_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/apt.13940","volume":"45","author":"G Conway","year":"2017","unstructured":"Conway G, Velonias G, Andrews  E, Garber JJ,  Yajnik V, Ananthakrishnan AN. The impact of co-existing immune-mediated on phenotype and outcomes in inflammatory bowel diseases. Aliment Pharmacol Ther 2017;45:814\u2013823.","journal-title":"Aliment Pharmacol Ther"},{"key":"8575_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ibd.21051","volume":"16","author":"AN Ananthakrishnan","year":"2010","unstructured":"Ananthakrishnan AN, Beaulieu DB, Ulitsky A et al. Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? Inflamm Bowel Dis 2010;16:494\u2013500.","journal-title":"Inflamm Bowel Dis"},{"key":"8575_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3748\/wjg.v21.i1.229","volume":"21","author":"R Shah","year":"2015","unstructured":"Shah R, Abraham B, Hou J, Sellin J. Frequency and associated factors of hair loss among patients with inflammatory bowel disease. World journal of gastroenterology\u202f: WJG 2015;21:229\u2013232.","journal-title":"World journal of gastroenterology : WJG"},{"key":"8575_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1159\/000512747","volume":"237","author":"J Maghfour","year":"2021","unstructured":"Maghfour J, Olson J, Conic RRZ, Mesinkovska NA. The Association between Alopecia and Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Dermatology 2021;237:658\u2013672.","journal-title":"Dermatology"},{"key":"8575_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/bjd.21704","volume":"187","author":"MC Schneeweiss","year":"2022","unstructured":"Schneeweiss MC, Kirchgesner J,  Wyss R et al. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study*. British Journal of Dermatology 2022;187:692\u2013703.","journal-title":"British Journal of Dermatology"},{"key":"8575_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/tpj.2015.43","volume":"16","author":"Y Kakuta","year":"2016","unstructured":"Kakuta Y, Naito T,  Onodera M et al. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. Pharmacogenomics J 2016;16:280\u2013285.","journal-title":"Pharmacogenomics J"},{"key":"8575_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00535-015-1142-4","volume":"51","author":"A Asada","year":"2016","unstructured":"Asada A, Nishida A,  Shioya M et al. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease. J Gastroenterol 2016;51:22\u201329.","journal-title":"J Gastroenterol"},{"key":"8575_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1590\/abd1806-4841.20153084","volume":"90","author":"LBP Ribeiro","year":"2013","unstructured":"Ribeiro LBP, Rego JC,  Estrada BD et al. Alopecia secondary to anti-tumor necrosis factor-alpha therapy. An Bras Dermatol 2013;90:232\u2013235.","journal-title":"An Bras Dermatol"},{"key":"8575_CR25","doi-asserted-by":"crossref","unstructured":"Lambert J, Schepper S, Speeckaert R. Cutaneous manifestations in biological-treated inflammatory bowel disease patients: a narrative review. J Clin Med 2021;10.","DOI":"10.3390\/jcm10051040"},{"key":"8575_CR26","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jaad.2014.03.005","volume":"70","author":"M Tauber","year":"2014","unstructured":"Tauber M, Buche S,  Reygagne P et al. Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective study. J Am Acad Dermatol 2014;70:1146\u20131149.","journal-title":"J Am Acad Dermatol"},{"key":"8575_CR27","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/rheumatology\/keu145","volume":"53","author":"J B\u00e9n\u00e9","year":"2014","unstructured":"B\u00e9n\u00e9 J, Moulis G,  Auffret M et al. Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database. Rheumatology 2014;53:1465\u20131469.","journal-title":"Rheumatology"},{"key":"8575_CR28","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/ecco-jcc\/jjac055","volume":"16","author":"MT Dolinger","year":"2022","unstructured":"Dolinger MT, Rolfes P, Spencer E,  Stoffels  G, Dunkin D, Dubinsky MC. Outcomes of children with inflammatory bowel disease who develop anti-tumor necrosis factor induced skin reactions. J Crohns Colitis 2022;16:1420\u20131427.","journal-title":"J Crohns Colitis"},{"key":"8575_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13555-022-00711-3","volume":"12","author":"BA King","year":"2022","unstructured":"King BA, Senna MM, Ohyama M et al. Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework. Dermatol Ther (Heidelb) 2022;12:825\u2013834.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"8575_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jid.2017.11.012","volume":"138","author":"JM Bae","year":"2018","unstructured":"Bae JM, Kim M,  Lee HH et al. Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study. Journal of Investigative Dermatology 2018;138:768\u2013774.","journal-title":"Journal of Investigative Dermatology"},{"key":"8575_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","volume":"26","author":"YR Yu","year":"2017","unstructured":"Yu YR, Rodriguez JR. Clinical presentation of Crohn\u2019s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg 2017;26:349\u2013355.","journal-title":"Semin Pediatr Surg"},{"key":"8575_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jpeds.2004.08.043","volume":"146","author":"MB Heyman","year":"2005","unstructured":"Heyman MB, Kirschner BS,  Gold BD et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005;146:35\u201340.","journal-title":"J Pediatr"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08575-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08575-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08575-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:31:33Z","timestamp":1726849893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08575-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["8575"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08575-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4214921\/v1","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}